Obadia L, Amador G, Daculsi G, Bouler J-M
Centre de Recherche INSERM 99-03 sur les Matériaux d'Intérêt Biologique, EM INSERM 99-03, BP 84125, Cedex 44042, Nantes, France.
Biomaterials. 2003 Mar;24(7):1265-70. doi: 10.1016/s0142-9612(02)00446-5.
The use of dynamic compaction and isostatic compression to consolidate calcium phosphate powder loaded with a therapeutic agent avoids a sintering step that could destroy the drug. The present study applied these consolidation methods to vancomycin-loaded calcium-deficient apatite powder, using three granulometric fractions (40-80, 80-200 and 200-500 micrometer). In vitro release profiles were determined via an original system derived from low-pressure liquid chromatography. The biological activity of vancomycin was measured by an in vitro standardized bacteriologic assay, which showed that the drug is completely active after association with calcium phosphate. Regardless of the consolidation method and granulometric fraction used, release profiles were not significantly different and therefore adaptable to injectable suspensions.
使用动态压实和等静压来固结负载治疗剂的磷酸钙粉末,避免了可能破坏药物的烧结步骤。本研究将这些固结方法应用于负载万古霉素的缺钙磷灰石粉末,使用了三种粒度级分(40 - 80、80 - 200和200 - 500微米)。通过源自低压液相色谱的原始系统测定体外释放曲线。通过体外标准化细菌学测定法测量万古霉素的生物活性,结果表明该药物与磷酸钙结合后完全具有活性。无论使用何种固结方法和粒度级分,释放曲线均无显著差异,因此适用于可注射悬浮液。